Alejandro L Suarez1, Nicolas T LaBarre2, Peter B Cotton3, K Mark Payne3, Gregory A Coté3, B Joseph Elmunzer3. 1. Division of Gastroenterology and Hepatology, Medical University of South Carolina, 114 Doughty St. MSC 702, Suite 249, Charleston, SC, 29425, USA. suareza@musc.edu. 2. Department of Medicine, Medical University of South Carolina, Charleston, SC, USA. 3. Division of Gastroenterology and Hepatology, Medical University of South Carolina, 114 Doughty St. MSC 702, Suite 249, Charleston, SC, 29425, USA.
Abstract
BACKGROUND: Prior studies have demonstrated that existing risk stratification guidelines for the evaluation of suspected choledocholithiasis lack accuracy, leading to the overutilization of endoscopic retrograde cholangiopancreatography (ERCP). The aim of our study was to evaluate the performance characteristics of published guidelines in predicting choledocholithiasis and to determine the impact of laboratory trends on diagnostic accuracy. METHODS: We identified patients with suspected choledocholithiasis hospitalized over a 5-year period (2009-2014) at a tertiary care academic medical center. Among eligible patients, we assessed the performance characteristics of the American Society for Gastrointestinal Endoscopy (ASGE) guidelines predicting the presence of choledocholithiasis, confirmed by endoscopic ultrasound, magnetic resonance cholangiography, ERCP, or intra-operative cholangiography. We also evaluated whether a second set of liver function tests improved the accuracy of the guidelines. RESULTS: On presentation, 71 of the 173 eligible patients (41.4 %) met ASGE high-probability criteria for choledocholithiasis. Of these, only 39 (54.9 %) were found to have a choledocholithiasis on confirmatory testing. Conversely, of the 102 patients (58.6 %) who were classified as low or intermediate probability, 32 (31.4 %) had choledocholithiasis. Overall, the accuracy of the guidelines was 63 % (sensitivity 54.9 %; specificity 68.6 %). Incorporating a second set of laboratory tests did not improve accuracy (62.7 %), and a significant decline in liver function tests did not reliably predict spontaneous stone passage. CONCLUSIONS: Existing guidelines performed suboptimally for predicting choledocholithiasis in our patient population, similar to other validation studies. These findings further underscore the importance of developing alternate risk stratification tools for choledocholithiasis, aiming to minimize unnecessary diagnostic ERCP.
BACKGROUND: Prior studies have demonstrated that existing risk stratification guidelines for the evaluation of suspected choledocholithiasis lack accuracy, leading to the overutilization of endoscopic retrograde cholangiopancreatography (ERCP). The aim of our study was to evaluate the performance characteristics of published guidelines in predicting choledocholithiasis and to determine the impact of laboratory trends on diagnostic accuracy. METHODS: We identified patients with suspected choledocholithiasis hospitalized over a 5-year period (2009-2014) at a tertiary care academic medical center. Among eligible patients, we assessed the performance characteristics of the American Society for Gastrointestinal Endoscopy (ASGE) guidelines predicting the presence of choledocholithiasis, confirmed by endoscopic ultrasound, magnetic resonance cholangiography, ERCP, or intra-operative cholangiography. We also evaluated whether a second set of liver function tests improved the accuracy of the guidelines. RESULTS: On presentation, 71 of the 173 eligible patients (41.4 %) met ASGE high-probability criteria for choledocholithiasis. Of these, only 39 (54.9 %) were found to have a choledocholithiasis on confirmatory testing. Conversely, of the 102 patients (58.6 %) who were classified as low or intermediate probability, 32 (31.4 %) had choledocholithiasis. Overall, the accuracy of the guidelines was 63 % (sensitivity 54.9 %; specificity 68.6 %). Incorporating a second set of laboratory tests did not improve accuracy (62.7 %), and a significant decline in liver function tests did not reliably predict spontaneous stone passage. CONCLUSIONS: Existing guidelines performed suboptimally for predicting choledocholithiasis in our patient population, similar to other validation studies. These findings further underscore the importance of developing alternate risk stratification tools for choledocholithiasis, aiming to minimize unnecessary diagnostic ERCP.
Authors: Sidney Cohen; Bruce R Bacon; Jesse A Berlin; David Fleischer; Gail A Hecht; Patrick J Loehrer; Alfred E McNair; Michael Mulholland; Nancy J Norton; Linda Rabeneck; David F Ransohoff; Amnon Sonnenberg; Michael W Vannier Journal: Gastrointest Endosc Date: 2002-12 Impact factor: 9.427
Authors: John T Maple; Tamir Ben-Menachem; Michelle A Anderson; Vasundhara Appalaneni; Subhas Banerjee; Brooks D Cash; Laurel Fisher; M Edwyn Harrison; Robert D Fanelli; Norio Fukami; Steven O Ikenberry; Rajeev Jain; Khalid Khan; Mary Lee Krinsky; Laura Strohmeyer; Jason A Dominitz Journal: Gastrointest Endosc Date: 2010-01 Impact factor: 9.427
Authors: Jingjing L Sherman; Emily W Shi; Nalin E Ranasinghe; Muthu T Sivasankaran; Jake G Prigoff; Celia M Divino Journal: Surgery Date: 2015-02-21 Impact factor: 3.982
Authors: Steffen Rickes; Gerhard Treiber; Klaus Mönkemüller; Ulrich Peitz; Antal Csepregi; Stefan Kahl; Anika Vopel; Kathleen Wolle; Matthias P A Ebert; Sabine Klauck; Peter Malfertheiner Journal: Scand J Gastroenterol Date: 2006-07 Impact factor: 2.423
Authors: Moises Ilan Nevah Rubin; Nirav C Thosani; Rajasekhar Tanikella; David S Wolf; Michael B Fallon; Frank J Lukens Journal: Dig Liver Dis Date: 2013-03-27 Impact factor: 4.088
Authors: Megan A Adams; Amy E Hosmer; Erik J Wamsteker; Michelle A Anderson; Grace H Elta; Nisa M Kubiliun; Richard S Kwon; Cyrus R Piraka; James M Scheiman; Akbar K Waljee; Hero K Hussain; B Joseph Elmunzer Journal: Gastrointest Endosc Date: 2015-03-16 Impact factor: 9.427
Authors: Yuk Tong Lee; Francis K L Chan; W K Leung; Henry L Y Chan; Justin C Y Wu; Man Yee Yung; Enders K W Ng; James Y W Lau; Joseph J Y Sung Journal: Gastrointest Endosc Date: 2007-12-26 Impact factor: 9.427
Authors: Chung Yao Yu; Nitzan Roth; Niraj Jani; Jaehoon Cho; Jacques Van Dam; Rick Selby; James Buxbaum Journal: Surg Endosc Date: 2019-03-25 Impact factor: 4.584
Authors: Camellia Dalai; John Azizian; Harry Trieu; Anand Rajan; Formosa Chen; Tien Dong; Simon Beaven; James H Tabibian Journal: Liver Res Date: 2021-10-22
Authors: Mauro Ariel Capparelli; Pablo Damian D Alessandro; Horacio Alberto Questa; Victor Hugo Ayarzabal; Maria Marcela Bailez; Marcelo Eugenio Barrenechea Journal: Pediatr Surg Int Date: 2021-06-19 Impact factor: 1.827
Authors: Yang Lei; B Cord Lethebe; Erin Wishart; Fateh Bazerbachi; B Joseph Elmunzer; Nirav Thosani; James L Buxbaum; Yen-I Chen; Sydney Bass; Martin J Cole; Christian Turbide; Darren R Brenner; Steven J Heitman; Rachid Mohamed; Nauzer Forbes Journal: J Clin Med Date: 2022-08-05 Impact factor: 4.964
Authors: Ausra Aleknaite; Gintaras Simutis; Juozas Stanaitis; Jonas Valantinas; Kestutis Strupas Journal: United European Gastroenterol J Date: 2017-09-06 Impact factor: 4.623